To maintain a structured and well-organized implementation plan it is important to have a lead agency or sector. The ministry of health or a similar authority in government will be critical in facilitating development and implementation of the multisectoral action plan.
Integrated Management of Adolescent and Adult Illness
Integrated Management of Childhood Illness
Interim Guidelines for health workers at health centre or district hospital outpatient clinic
Summary of the Ethopian country office of WHO on COVID-19 activities.
This updated version, endorsed by the World Health Assembly in May 2021 through resolution WHA74.9, reflects lessons learned in the global malaria response over the last 5 years. While the milestones and targets remain the same, the approaches to tackling the disease, in some areas, have evolved to ...keep pace with the changing malaria landscape.
more
21 августа 2020 г.
В этом документе представлены рекомендации для лиц, принимающих решения, работников общественного
здравоохранения и специалистов в области педиа...рии, касающиеся использования детских масок в условиях пандемии
COVID-19.
more
Despite the development of point-of-care diagnostic tests for syphilis, chlamydia, gonorrhoea, and trichomoniasis, none comply with all WHO criteria. This analysis overviews landscape analyses of point-of-care diagnostic technologies for Chlamydia trachomatis, Neisseria gonorrhoeae, Trichomonas vagi...nalis and syphilis, available and in the pipeline. The target audience for the target product profiles is broad and includes clinicians, researchers working on diagnostics, laboratory experts, including, microbiologists and virologists, public health experts, epidemiologists, developers, and representatives for manufactures, including biotech engineers, policy-and decision-makers as well as representatives from regulatory bodies and agencies, donor agencies and international organizations.
more
The goal of the draft global action plan is to ensure, for as long as possible, continuity of successful treatment and prevention of infectious diseases with effective and safe medicines that are quality-assured, used in a responsible way, and accessible to all who need them.
An example of integration of research into epidemic response.
Настоящее «Руководство по обеспечению качества питьевой воды: маломасштабные системы водоснабжения» было разработано для удовлетворения потребностей и использ...вания возможностей, связанных с маломасштабными системами водоснабжения, в целях содействия постоянному совершенствованию системы устойчивого снабжения всего населения безопасной питьевой водой. Настоящее Руководство основано на главной рекомендации Руководства по обеспечению качества питьевой воды Всемирной организации здравоохранения и содержит руководящие указания в отношении выполнения этой рекомендации, в частности применительно к маломасштабным системам водоснабжения. Настоящее Руководство призвано помочь правительствам и отрасли повысить безопасность питьевой воды, доставляемой маломасштабными системами водоснабжения.
more
India reported its 1st case of COVID-19 on 30th January, 2020. It was a travel related case from Wuhan, China. Since then (as on 29th March, 2020), 979 confirmed cases and 25 deaths have been reported from 27 States/UTs. Although there is no evidence to widespread community transmission, 20 existing... and 22 potential hotspots have been identified. The containment measures to break the cycle of transmission and clinical management of those affected would require large human resource (HR).
more
Este documento resume as orientações provisórias da OMS para a vigilância global de novas infecções pelo coronavírus 2019-nCoV (COVID-19). A OMS continuará atualizando essas orientações à medida que novas informações sobre 2019-nCoV estiverem disponíveis. Este documento fornece orienta...ções aos Estados-Membros sobre a implementação da vigilância global de 2019-nCoV.
more
n light of the potential risk posed by SARS-CoV-2 variants, in January 2021 WHO organized an ad hoc consultation to discuss the development of an R&D agenda in response to existing and emerging SARS-CoV-2 variants.
The key objectives were to identify the critical research questions related to var...iants and agree on a research approach to address them. Six breakout groups covered a range of specific issues related to COVID-19 variants: Epidemiology and mathematical modelling; evolutionary biology; animal models; assays and diagnostics; clinical management and therapeutics; and vaccines.
This report is a summary of presentations and panel discussions.
more